The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD). The initiative begins with the first national prevalence study to gain a better understanding of the spread of this virulent pathogen.
C. difficile is a life-threatening bacterium that causes diarrhea and more serious intestinal conditions such as colitis and is frequently associated with prolonged antibiotic use. CDAD is most commonly contracted by the elderly and those with recent exposure to hospitals, nursing homes and other healthcare institutions. Over the past several years, a more toxic strain of C. difficile has emerged causing outbreaks in healthcare facilities worldwide.
“We are concerned by reports of increasing infection rates and severity of CDAD,” said APIC Chief Executive Officer Kathy L. Warye. “Not only does it lead to longer hospital stays, which result in higher healthcare costs, but deaths from C. difficile infections also are on the rise. Because the true magnitude of this infection is unknown, our objective is to provide the first national estimate of C. difficile infection in inpatients in U.S. healthcare facilities.”
The APIC Research Foundation C. difficile Prevalence Study will be conducted May 1 to May 23, 2008. More than 5,000 healthcare facilities are being invited to participate by providing a one-day snapshot of C. difficile infections within their institution.
Following the survey, APIC will develop a Guide to the Elimination of C. difficile, including strategies for controlling transmission as well as an educational Webinar series. The Association also will hold a conference in late 2008, featuring results of the prevalence study, along with the latest science, epidemiology and best practices for the elimination of C. difficile transmission.
“Following our positive experience in having taken a very comprehensive approach to MRSA in 2007, APIC will launch a similar aggressive fight against C. difficile in 2008,” said Warye. “APIC will lead a national effort to arm infection prevention professionals with the comprehensive tools necessary to eradicate this virulent pathogen and reduce C. difficile infections. Prevention efforts are crucial because our arsenal of effective treatment agents is thin, and the organism is rapidly developing resistance.”
Source: Association for Professionals in Infection Control
Related stories:
Breakthrough in the fight against deadly superbug
(PhysOrg.com) -- The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.
Online courses boost infection control skills that could prove vital in a pandemic
Online courses are helping staff to develop the skills they need to tackle hospital-acquired infections, such as MRSA and
C.difficile, and this expertise could also prove vital in a pandemic, according to a study published in the latest issue of the UK-based
Journal of Advanced Nursing.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.
Less hype and more research needed into new 'superbug,' say experts
Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the
BMJ.
The balance shifts
The risk of contracting a Clostridium difficile infection following operations for which a "prophylactic" antibiotic is given to prevent infection is 21 times greater now than it was just a decade ago, according to researchers from the University of Sherbrooke in Canada. They report their findings in the June 15 issue of
Clinical Infectious Diseases, currently available online.
UV lotion lights the way to cleaner facilities
A team of Canadian scientists using a lotion which glows under ultraviolet light have shown that up to a third of patient toilets are not properly cleaned. Their findings, published in BioMed Central’s journal,
BMC Infectious Diseases, also show that spores from the nasty bacteria Clostridium difficile (C. difficile) linger in the loo even when it has been thoroughly wiped down.
MRSA in hospital intensive care -- what's growing where?
Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.
Modern matron struggling to fulfil role as leader
Experts at The University of Nottingham say ‘modern matrons’ — with their managerial and entrepreneurial skills — are struggling to fulfil their role as leader, and this remains a major challenge in a crucially important area of healthcare.